Viewing Study NCT00293267


Ignite Creation Date: 2025-12-25 @ 12:33 AM
Ignite Modification Date: 2025-12-25 @ 10:40 PM
Study NCT ID: NCT00293267
Status: COMPLETED
Last Update Posted: 2015-09-07
First Post: 2006-02-14
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: A Study to Evaluate the Safety and Efficacy of Raltegravir (MK0518) in HIV-Infected Patients Failing Current Antiretroviral Therapies (MK0518-018 EXT2)
Sponsor: Merck Sharp & Dohme LLC
Organization: